Stage III Prostate Cancer

Showing 26 - 49 of 49

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Malignant Tumor, Cervical Squamous Cell Carcinoma, Endometrial Carcinoma Trial in Scottsdale, Rochester (Laboratory

Completed
  • Advanced Malignant Neoplasm
  • +31 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Scottsdale, Arizona
  • +1 more
Jun 5, 2019

Prostate Adenocarcinoma, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer Trial in Seattle (drug, radiation, other)

Completed
  • Prostate Adenocarcinoma
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 21, 2018

Adenocarcinoma of the Prostate, Castration-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Seattle (Cabozantinib)

Terminated
  • Adenocarcinoma of the Prostate
  • +4 more
  • Seattle, Washington
    Seattle Cancer Care Alliance/University of Washington
Nov 6, 2018

Adenocarcinoma of the Prostate, Bone Metastases, Soft Tissue Metastases Trial in Aurora (Ranolazine)

Completed
  • Adenocarcinoma of the Prostate
  • +6 more
  • Aurora, Colorado
    University of Colorado Cancer Center
Nov 29, 2018

Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage I Prostate Cancer Trial in Detroit (bevacizumab, laboratory

Completed
  • Adenocarcinoma of the Prostate
  • +5 more
  • bevacizumab
  • laboratory biomarker analysis
  • Detroit, Michigan
  • +1 more
Jul 1, 2018

Stage III Prostate Cancer Trial (dietary supplement, other, procedure)

Withdrawn
  • Stage III Prostate Cancer
  • omega-3 fatty acid
  • +4 more
  • (no location specified)
Jul 2, 2018

Adenocarcinoma of the Prostate, Stage II Prostate Cancer, Stage III Prostate Cancer Trial in Seattle (drug, genetic, other,

Completed
  • Adenocarcinoma of the Prostate
  • +2 more
  • sorafenib tosylate
  • +8 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Nov 20, 2017

Prostate Adenocarcinoma, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in United States (drug, other, procedure)

Completed
  • Prostate Adenocarcinoma
  • +4 more
  • Los Angeles, California
  • +14 more
Sep 18, 2017

Prostate Adenocarcinoma, Recurrent Prostate Carcinoma, Stage III Prostate Cancer Trial in Buffalo (dietary supplement, drug,

Terminated
  • Prostate Adenocarcinoma
  • +3 more
  • Calcitriol
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
May 15, 2017

Stage III Prostate Cancer Trial in Tianjin (procedure, radiation, drug)

Unknown status
  • Stage III Prostate Cancer
  • Cryoablation therapy
  • +3 more
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Hospital
Jun 9, 2017

Adenocarcinoma of the Prostate, Stage II Prostate Cancer, Stage III Prostate Cancer Trial in Seattle, Tacoma (drug, other,

Completed
  • Adenocarcinoma of the Prostate
  • +3 more
  • abiraterone acetate
  • +5 more
  • Seattle, Washington
  • +1 more
May 3, 2017

Prostate Cancer, Adenocarcinoma of the Prostate, Recurrent Prostate Cancer Trial in Orange (sunitinib malate, docetaxel,

Terminated
  • Prostate Cancer
  • +5 more
  • sunitinib malate
  • +2 more
  • Orange, California
    Chao Comprehensive Cancer Center
Dec 6, 2016

Prostate Adenocarcinoma, Stage IIB Prostate Cancer, Stage III Prostate Cancer Trial in Philadelphia (radiation, procedure,

Completed
  • Prostate Adenocarcinoma
  • +3 more
  • Copper Cu 64 TP3805
  • +4 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Oct 19, 2016

Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in Ann Arbor (cilengitide)

Completed
  • Recurrent Prostate Cancer
  • +4 more
  • Ann Arbor, Michigan
    University of Michigan University Hospital
Mar 28, 2016

Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage IIB Prostate Cancer Trial in Sacramento (perifosine, laboratory

Terminated
  • Adenocarcinoma of the Prostate
  • +4 more
  • Sacramento, California
    UC Davis Cancer Center
Feb 9, 2015

Diarrhea, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Los Angeles (cabazitaxel, prednisone, octreotide

Terminated
  • Diarrhea
  • +7 more
  • Los Angeles, California
    USC/Norris Comprehensive Cancer Center
Nov 21, 2014

Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in Philadelphia (lapatinib ditosylate,

Completed
  • Recurrent Prostate Cancer
  • +4 more
  • lapatinib ditosylate
  • laboratory biomarker analysis
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
Sep 19, 2014

Bone Metastases, Recurrent Prostate Cancer, Stage I Prostate Cancer Trial in Boston (procedure, radiation, other)

Completed
  • Bone Metastases
  • +6 more
  • magnetic resonance imaging
  • +5 more
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Jul 1, 2014

Adenocarcinoma of the Prostate, Stage III Prostate Cancer, Stage IV Prostate Cancer Trial in Houston (antineoplaston A10,

Withdrawn
  • Adenocarcinoma of the Prostate
  • +3 more
  • antineoplaston A10
  • +13 more
  • Houston, Texas
    Burzynski Clinic
Jul 9, 2013

Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial (atorvastatin calcium, )

Withdrawn
  • Recurrent Prostate Cancer
  • +5 more
  • atorvastatin calcium
  • placebo
  • (no location specified)
Jun 17, 2013

Advanced Adult Primary Liver Cancer, Anaplastic Thyroid Cancer, Bone Metastases Trial in Columbus (recombinant interleukin-12,

Completed
  • Advanced Adult Primary Liver Cancer
  • +126 more
  • recombinant interleukin-12
  • ABI-007/carboplatin/trastuzumab
  • Columbus, Ohio
    Ohio State University Medical Center
Feb 27, 2013

Recurrent NSCLC, Recurrent Prostate Cancer, Stage III Prostate Cancer Trial in Toronto (biological, drug, other)

Completed
  • Recurrent Non-small Cell Lung Cancer
  • +7 more
  • GTI-2040
  • +3 more
  • Toronto, Ontario, Canada
    Princess Margaret Hospital Phase 2 Consortium
Jan 23, 2013